Impact of enzyme replacement therapy and migalastat on left atrial strain and cardiomyopathy in patients with Fabry disease

AimsCardiomyopathy in Fabry disease (FD) is a major determinant of morbidity and mortality. This study investigates the effects of FD-specific treatment using enzyme replacement therapy (ERT) and chaperone therapy on left atrial (LA) function using two-dimensional speckle tracking echocardiography (...

詳細記述

書誌詳細

出版年:	Frontiers in Cardiovascular Medicine
主要な著者:	Christian Pogoda, Stefan-Martin Brand, Thomas Duning, Antje Schmidt-Pogoda, Jürgen Sindermann, Malte Lenders, Eva Brand
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2023-11-01
主題:	cardiomyopathy Fabry disease migalastat enzyme replacement therapy left atrial strain speckle tracking
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fcvm.2023.1223635/full